Christine from Northern Ireland shares her experience of LDN as a treatment for Multiple Sclerosis (MS) (low dose naltrexone) from LDN Research Trust on Vimeo.
Christine is from Belfast, but originally from the United States. She was diagnosed to have multiple sclerosis (MS) in 2000 after 5 years of problems without a diagnosis. Her first symptom was a bout of optic neuritis in 1995; at diagnosis in 2000 she was put on interferon for about 16 months but refused it finally because her symptoms and relapses were worse. She heard about low dose naltrexone (LDN) and found a prescriber, and felt almost immediate improvement on LDN; and rates her quality of live as improved from 5, to between 8 and 10. The only side effect was vivid dreams, but she is able to adjust her dosage if that is an issue.
Christine still has numbness in her right hand, occasional fatigue, but feels Low Dose Naltrexone - LDN worked wonders for her, and it is low cost and safe, unlike other pharmaceuticals. She encourages others to try it.
Christine gave appreciation for the information provided through the LDN Research Trust, particularly information for GPs.
Summary of Christine’s interview, please listen to the video for the full story.
Keywords: LDN, low dose naltrexone, multiple sclerosis, MS, optic neuritis, fatigue
Any questions or comments you may have, email us at contact@ldnresearchtrust.org.